{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:27:59Z","timestamp":1793662079459,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE 2140743"],"award-info":[{"award-number":["DGE 2140743"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI155765"],"award-info":[{"award-number":["R01AI155765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57174-1","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T23:47:06Z","timestamp":1741045626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multivariable regression models improve accuracy and sensitive grading of antibiotic resistance mutations in Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9883-610X","authenticated-orcid":false,"given":"Sanjana G.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4610-2427","authenticated-orcid":false,"given":"Paolo","family":"Miotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Chindelevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Michael","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7696-3776","authenticated-orcid":false,"given":"Nazir","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Rodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-5760","authenticated-orcid":false,"given":"Maha R.","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"57174_CR1","first-page":"mgen001081","volume":"9","author":"MB Hall","year":"2023","unstructured":"Hall, M. B., Lima, L., Coin, L. J. M. & Iqbal, Z. Drug resistance prediction for Mycobacterium tuberculosis with reference graphs. Microb. Genom. 9, mgen001081 (2023).","journal-title":"Microb. Genom."},{"key":"57174_CR2","unstructured":"WHO. The use of next-generation sequencing for the surveillance of drug-resistant tuberculosis: An implementation manual (World Health Organization, 2023)."},{"key":"57174_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.12688\/wellcomeopenres.15603.1","volume":"4","author":"M Hunt","year":"2019","unstructured":"Hunt, M. et al. Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe. Wellcome open Res. 4, 191 (2019).","journal-title":"Wellcome open Res."},{"key":"57174_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0650-x","volume":"11","author":"J Phelan","year":"2019","unstructured":"Phelan, J. et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. Genome Med. 11, 41 (2019).","journal-title":"Genome Med."},{"key":"57174_CR5","doi-asserted-by":"publisher","first-page":"1701354","DOI":"10.1183\/13993003.01354-2017","volume":"50","author":"P Miotto","year":"2017","unstructured":"Miotto, P. et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur. Respir. J. 50, 1701354 (2017).","journal-title":"Eur. Respir. J."},{"key":"57174_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","volume":"15","author":"TM Walker","year":"2015","unstructured":"Walker, T. M. et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect. Dis. 15, 1193\u20131202 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"57174_CR7","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","volume":"3","author":"TM Walker","year":"2022","unstructured":"Walker, T. M. et al. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis. Lancet Microbe 3, e265\u2013e273 (2022).","journal-title":"Lancet Microbe"},{"key":"57174_CR8","unstructured":"WHO. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, second edition (World Health Organization, 2023)."},{"key":"57174_CR9","doi-asserted-by":"crossref","unstructured":"Lewis, C.M. & Vassos, E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 12, 44 (2020).","DOI":"10.1186\/s13073-020-00742-5"},{"key":"57174_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10110-6","volume":"10","author":"MR Farhat","year":"2019","unstructured":"Farhat, M. R. et al. GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions. Nat. Commun. 10, 2128 (2019).","journal-title":"Nat. Commun."},{"key":"57174_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44325-5","volume":"15","author":"CRyPTIC Consortium.","year":"2024","unstructured":"CRyPTIC Consortium. Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach. Nat. Commun. 15, 488 (2024).","journal-title":"Nat. Commun."},{"key":"57174_CR12","doi-asserted-by":"publisher","first-page":"2200239","DOI":"10.1183\/13993003.00239-2022","volume":"60","author":"CRyPTIC Consortium.","year":"2022","unstructured":"CRyPTIC Consortium. Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis. Eur. Respir. J. 60, 2200239 (2022).","journal-title":"Eur. Respir. J."},{"key":"57174_CR13","doi-asserted-by":"publisher","first-page":"2100621","DOI":"10.1183\/13993003.00621-2021","volume":"59","author":"E Chesov","year":"2022","unstructured":"Chesov, E. et al. Emergence of bedaquiline resistance in a high tuberculosis burden country. Eur. Respir. J. 59, 2100621 (2022).","journal-title":"Eur. Respir. J."},{"key":"57174_CR14","first-page":"684","volume":"72","author":"C Villellas","year":"2017","unstructured":"Villellas, C. et al. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline. J. Antimicrob. Chemother. 72, 684\u2013690 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"57174_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1473-3099(23)00498-X","volume":"24","author":"I Barilar","year":"2024","unstructured":"Barilar, I. et al. Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB\/RIF in Mozambique: a retrospective observational study. Lancet Infect Dis. 24, 297\u2013307 (2024).","journal-title":"Lancet Infect Dis."},{"key":"57174_CR16","doi-asserted-by":"publisher","first-page":"e00322","DOI":"10.1128\/aac.00322-22","volume":"66","author":"E Rivi\u00e8re","year":"2022","unstructured":"Rivi\u00e8re, E. et al. Variants in Bedaquiline-Candidate-resistance genes: prevalence in bedaquiline-naive patients, effect on MIC, and association with mycobacterium tuberculosis lineage. Antimicrob. Agents Chemother. 66, e00322\u2013e00322 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"57174_CR17","doi-asserted-by":"publisher","first-page":"e100078","DOI":"10.1371\/journal.pone.0100078","volume":"9","author":"T Jagielski","year":"2014","unstructured":"Jagielski, T. et al. Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland. PloS ONE 9, e100078 (2014).","journal-title":"PloS ONE"},{"key":"57174_CR18","doi-asserted-by":"publisher","first-page":"e0116421","DOI":"10.1128\/AAC.01164-21","volume":"65","author":"R Vargas Jr","year":"2021","unstructured":"Vargas, R. Jr et al. Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine resistance in Mycobacterium tuberculosis complex. Antimicrob. Agents Chemother. 65, e0116421 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"57174_CR19","doi-asserted-by":"publisher","first-page":"267.e5","DOI":"10.1016\/j.cmi.2016.12.009","volume":"23","author":"E Andr\u00e9","year":"2017","unstructured":"Andr\u00e9, E. et al. Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays. Clin. Microbiol. Infect. 23, 267.e5\u2013267.e7 (2017).","journal-title":"Clin. Microbiol. Infect."},{"key":"57174_CR20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/ng.2747","volume":"45","author":"MR Farhat","year":"2013","unstructured":"Farhat, M. R. et al. Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat. Genet. 45, 1183\u20131189 (2013).","journal-title":"Nat. Genet."},{"key":"57174_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00726-5","volume":"12","author":"M Merker","year":"2020","unstructured":"Merker, M. et al. Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex. Genom. Med. 12, 27 (2020).","journal-title":"Genom. Med."},{"key":"57174_CR22","unstructured":"WHO. Target product profile for next-generation drug-susceptibility testing at peripheral centres (World Health Organization, 2021)"},{"key":"57174_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1365-2958.2004.04078.x","volume":"52","author":"VH Ng","year":"2004","unstructured":"Ng, V. H., Cox, J. S., Sousa, A. O., MacMicking, J. D. & McKinney, J. D. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52, 1291\u20131302 (2004).","journal-title":"Mol. Microbiol."},{"key":"57174_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05354-5","volume":"7","author":"CF Wong","year":"2017","unstructured":"Wong, C. F. et al. AhpC of the mycobacterial antioxidant defense system and its interaction with its reducing partner Thioredoxin-C. Sci. Rep. 7, 5159 (2017).","journal-title":"Sci. Rep."},{"key":"57174_CR25","unstructured":"Information sheet: Practical considerations for implementation of the Cepheid Xpert MTB\/XDR test (Stop TB Partnership, 2024)."},{"key":"57174_CR26","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1128\/AAC.41.9.2057","volume":"41","author":"CL Kelley","year":"1997","unstructured":"Kelley, C. L., Rouse, D. A. & Morris, S. L. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41, 2057\u20132058 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"57174_CR27","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1126\/science.272.5268.1641","volume":"272","author":"DR Sherman","year":"1996","unstructured":"Sherman, D. R. et al. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272, 1641\u20131643 (1996).","journal-title":"Science"},{"key":"57174_CR28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1046\/j.1365-2958.1996.449980.x","volume":"19","author":"TM Wilson","year":"1996","unstructured":"Wilson, T. M. & Collins, D. M. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol. Microbio. 19, 1025\u20131034 (1996).","journal-title":"Mol. Microbio."},{"key":"57174_CR29","doi-asserted-by":"publisher","first-page":"13212","DOI":"10.1073\/pnas.93.23.13212","volume":"93","author":"Y Zhang","year":"1996","unstructured":"Zhang, Y., Dhandayuthapani, S. & Deretic, V. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. PNAS 93, 13212\u201313216 (1996).","journal-title":"PNAS"},{"key":"57174_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.201510-2091OC","volume":"194","author":"MR Farhat","year":"2016","unstructured":"Farhat, M. R. et al. Genetic determinants of drug resistance in Mycobacterium tuberculosis and their diagnostic value. Am. J. Respir. Critic. Care Med. 194, 621\u2013630 (2016).","journal-title":"Am. J. Respir. Critic. Care Med."},{"key":"57174_CR31","unstructured":"WHO. Public call for whole genome sequencing and phenotypic data from clinical isolates of M. tuberculosis complex (World Health Organization, 2022)."},{"key":"57174_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrmicro.2018.8","volume":"16","author":"S Gagneux","year":"2018","unstructured":"Gagneux, S. Ecology and evolution of Mycobacterium tuberculosis. Nat. Rev. Microbiol. 16, 202\u2013213 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"57174_CR33","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/nmicrobiol.2016.41","volume":"1","author":"S Earle","year":"2016","unstructured":"Earle, S. et al. Identifying lineage effects when controlling for population structure improves power in bacterial association studies. Nat. Microbiol. 1, 16041 (2016).","journal-title":"Nat. Microbiol."},{"key":"57174_CR34","doi-asserted-by":"publisher","first-page":"e2301394120","DOI":"10.1073\/pnas.2301394120","volume":"120","author":"R Vargas Jr","year":"2023","unstructured":"Vargas, R. Jr et al. Phase variation as a major mechanism of adaptation in Mycobacterium tuberculosis complex. PNAS 120, e2301394120 (2023).","journal-title":"PNAS"},{"key":"57174_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31236-0","volume":"13","author":"AG Green","year":"2022","unstructured":"Green, A. G. et al. A convolutional neural network highlights mutations relevant to antimicrobial resistance in Mycobacterium tuberculosis. Nat. Commun. 13, 3817 (2022).","journal-title":"Nat. Commun."},{"key":"57174_CR36","doi-asserted-by":"crossref","unstructured":"Freschi, L. et al. Population structure, biogeography and transmissibility of Mycobacterium tuberculosis. Nat. Commun. 12, 6099 (2021).","DOI":"10.1038\/s41467-021-26248-1"},{"key":"57174_CR37","doi-asserted-by":"crossref","unstructured":"Coll, F. et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat. Commun. 5, 4812 (2014).","DOI":"10.1038\/ncomms5812"},{"key":"57174_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3201\/eid2503.180894","volume":"25","author":"S Lipworth","year":"2019","unstructured":"Lipworth, S. et al. SNP-IT Tool for identifying subspecies and associated lineages of Mycobacterium tuberculosis Complex. Emerg. Infect. Dis. 25, 482\u2013488 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"57174_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2005-6-5-r44","volume":"6","author":"K Eilbeck","year":"2005","unstructured":"Eilbeck, K. et al. The sequence ontology: a tool for the unification of genome annotations. Genome Biol. 6, R44 (2005).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57174-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T11:40:02Z","timestamp":1741088402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57174-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57174"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57174-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.C.R. received funding support from FIND through a service contract with UC San Diego. T.C.R. received grant funding from NIH to develop and evaluate a tNGS solution for drug resistant TB (R01AI176401). T.C.R. is a co-founder, board member and unpaid shareholder of Verus Diagnostics Inc. T.C.R. is a co-inventor on patents pertaining to tNGS. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2149"}}